Portfolio Thuja Capital Healthcare Seed Fund I
Fabpulous develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability (lateral flow). The first application is a rapid h-FAPB test as an aid in the early diagnosis of a heart infarct.
Cavadis is a biomarker company aiming to develop in vitro diagnostics for cardiovascular risk assessment.
arGEN-X is monoclonal antibody company employing proprietory superior therapeutic antibody discovery platform to develop own antibody product portfolio.
Akeso is a medical technology company (Philips spin-out), developing an imaging apparatus to measure and monitor rheumatoid arthritis disease activity in the joints of the hands.
DCPrime is a biotech company with a proprietary allogeneic dendritic cell line as a platform to derive and develop the next generation therapeutic dendritic cancer vaccines.
NightBalance is a medtech company developing and commercializing a patient-friendly device to treat positional sleep apnea.